Why Pediatric ROTEM Needs Race-Specific Reference Ranges?
Vera Ignjatovic, Founder and Managing Director of Ignis Innovations Pty Ltd, shared a post by Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
”Here is the link to our paper describing the age and race-specific association of fibrinogen and Rotational Thromboelastometry (ROTEM) parameters in a diverse pediatric population.
Inclusion of a diverse population in establishing race-specific pediatric RIs has clinical and public health relevance for a more accurate diagnosis and personalized treatment.
Thank you, Marium Malik, Maha Al-Ghafry, Maribel Lema, Vijay Nandi, Linda Shore-Lesserson, and Suchitra S. Acharya for making this study possible. I am privileged to have worked with you in the late stages of this study.”
Quoting Journal of Thrombosis and Haemostasis (JTH)’s post:
”Association of fibrinogen and ROTEM parameters with age and race in a diverse pediatric population: a single-center study
By Marium Malik, Maha Al-Ghafry, Maribel Lema, Vijay Nandi, Vera Ignjatović, Linda Shore-Lesserson, and Suchitra S. Acharya
• Pediatric reference ranges for Rotational Thromboelastometry (ROTEM) – a whole-blood coagulation assay – are limited and rarely account for racial diversity.
• In 105 racially diverse children (1–21 years), investigators analyzed how age and race affect fibrinogen and ROTEM variables (EXTEM, INTEM, and FIBTEM).
• Fibrinogen and FIBTEM clot strength increased with age. Among Black/African American participants, rising age correlated with shorter clot times and stronger clot firmness, suggesting a prothrombotic hemostatic profile. This underscores the need for race-specific pediatric reference intervals for personalized coagulation assessment.
Read the article here.”
Title: Association of fibrinogen and Rotational Thromboelastometry (ROTEM) parameters with age and race in a diverse pediatric population: a single-center study
Authors: Marium Malik, Maha Al-Ghafry, Maribel Lema, Vijay Nandi, Vera Ignjatovic, Linda Shore-Lesserson, Suchitra S. Acharya
Stay updated with Hemostasis Today.
-
Apr 6, 2026, 04:17Arun V J: How War Reshaped Blood Transfusion
-
Apr 6, 2026, 03:57Isabella Cieri: How TEG Is Transforming Vascular Surgery Care
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD
-
Apr 5, 2026, 17:42Josu de la Fuente: Real World Data Shows Significant Risk of Subsequent HCT in SCD and Thalassemia
-
Apr 5, 2026, 17:41Gevorg Yaghjyan: Attending an AI Conference on AI in Clinical Medicine, Research and Education